DRNA
COM:DICERNA
Novo Nordisk
- Stock
locale
United Statesmarket
STOCKSindustry
Pharmaceuticalswebsite
www.dicerna.comipo date
Jan 30, 2014
Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercializing of ribonucleic acid interference (RNAi)-based pharmaceuticals. The company develops pharmaceuticals using its GalXC RNAi platform for the treatment of diseases involving the liver, including rare, cardiometabolic, viral, and chronic liver diseases; complement-m...Show More